Lidocain Accord (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the influx of sodium ions that initiates action potentials. This stabilises the nerve membrane, halting the transmission of pain signals and producing a temporary loss of sensation in the treated area.

The appropriate dose of Lidocain Accord is determined by the prescribing clinician based on the specific procedure, patient weight, age, and clinical condition. Healthcare professionals calculate the dose to achieve effective anesthesia while maintaining safety.

Safety data for lidocaine during pregnancy and lactation are limited. Use is generally reserved for situations where the benefit to the mother outweighs potential risks to the fetus or infant. Clinicians should evaluate each case individually and follow local guidelines.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

The primary alternative to lidocaine is bupivacaine, another long‑acting local anesthetic. Lidocaine has a faster onset but a shorter duration of action, making it suitable for shorter procedures. Bupivacaine provides prolonged analgesia but carries a higher risk of cardiotoxicity at comparable doses.

Lidocain Accord should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from moisture, direct sunlight and extreme temperatures. Do not freeze; discard any product that appears cloudy or contains particles.

The product is administered by a qualified healthcare professional via epidural, intramuscular or intravenous injection. The route, volume and rate are selected according to the clinical indication, patient condition and procedural requirements, following aseptic technique.

Serious risks include allergic reactions such as anaphylaxis, cardiac arrhythmias, seizures, and methemoglobinemia. These events are rare but require immediate medical attention. Monitoring of cardiovascular and neurological status is recommended during and after administration.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid the product. It is also contraindicated in individuals with severe hepatic impairment, certain cardiac conduction disorders, or when used concurrently with drugs that markedly increase lidocaine plasma levels.